Buch, Englisch, 444 Seiten, Format (B × H): 183 mm x 275 mm, Gewicht: 1290 g
Evaluation and Management
Buch, Englisch, 444 Seiten, Format (B × H): 183 mm x 275 mm, Gewicht: 1290 g
ISBN: 978-1-84184-630-9
Verlag: Taylor & Francis Ltd
Overactive bladder (OAB) affects millions of men and women daily. Given the symptoms of sleep loss, depression, and a lower quality of life than even those with diabetes mellitus, effective and beneficial treatment is a must for these people. Drs Kreder and Dmochowski, both recognized experts on voiding dysfunction and urodynamics, have assembled a distinguished team of experts from around the globe to share with the reader, whether qualified or in-training, their perspectives based both on best practice and personal experience in evaluating and managing the overactive bladder. This seminal work should guide the reader in daily practice.
Zielgruppe
Professional Reference
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
Section 1, INTRODUCTION 1. Nomenclature. 2. The Neurophysiology of Lower Urinary Tract Function. 3. The Diagnosis of Overactive Bladder. 4. Measuring OAB Symptoms. 5. Nocturia. 6. Urodynamics. 7. Urgency-Frequency Syndome and Pelvic Pain, and Interstitial Cystitis. 8. Pelvic Floor Muscle Exercises and Behavioral Therapy. Section 2, PHARMACOLOGY 9. Basic Pharmacology. 10. Drug Delivery and Intravesical Instillation. 11. Pioneering Agents: Immediate-Release. 12. Tricyclic Antidepressants. 13. Propiverine Hydrochloride. 14. Extended Release Oral Oxybutynin. 15. Tolterodine. 16. Trospium Chloride. 17. Darifenacin. 18. Solifenacin Succinate. 19. Transdermal Oxybutynin (Oxytrol). 20. Strategies for Data Comparison for Drugs. 21. Pharmacotherapy of OAB in Bladder Outlet Obstruction. 22. Botulinum Toxin (Botox). 23. Acupuncture. 24. Fesoterodine. Section 3, NEUROMODULATION 25. Neuromodulation: Mechanisms of Action. 26. Sacral Nerve Stimulation. 27. The Bion Microstimulator. 28. The Miniaturo-I Device. Section 4, SURGICAL THERAPY 29. Transvaginal Denervation. 30. Autoaugmentation. 31. Augmentation Cystoplasty. Section 5, SPECIAL CONSIDERATIONS 32. Children. 33. Geriatric Population 34. Late Breaking Information
